Literature DB >> 1350796

Which anti-hypertensive to add to a beta-blocker: ACE inhibitor or diuretic?

M Huttunen1, E Lampainen, M Lilja, M Ikäheimo, J Kontro, P Mäkynen, A Savolainen.   

Abstract

Thirty-eight patients already treated with atenolol 50 mg once daily were randomly assigned to treatment with either hydrochlorothiazide (12.5-25 mg once daily) or lisinopril (10-20 mg once daily) for 8 weeks in a double-blind crossover study. Eight weeks' treatment with the combination of ACE inhibitor and beta-blocker or the diuretic and beta-blocker produced falls in blood pressure (lying: -8.4 +/- 15.4/ -7.3 +/- 80 mmHg and -6.1 +/- 15.3/ -5.2 +/- 8.8 mmHg [mean +/- SD] for lisinopril and hydrochlorothiazide respectively; standing: -10.2 +/- 14.2/8.2 +/- 9.2 mmHg and -6.8 +/- 14/ -6.3 +/- 10.3 mmHg for lisinopril and hydrochlorothiazide respectively) which were not statistically significantly different. Heart rate was significantly increased on the combination of beta-blocker and diuretic (lying: +4.3 +/- 10.7; standing: +3.2 +/- 10.0 beats/min) compared with a fall on beta-blocker+ACE inhibitor (lying; -0.5 +/- 7.6; standing: -1.5 +/- 7.4). Both therapeutic regimens were equally well tolerated. These results suggest that where patients fail to respond to monotherapy with a beta-blocker the addition of an ACE inhibitor may be as effective as the more traditional option of diuretic therapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350796

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  3 in total

1.  Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.

Authors:  George L Bakris; Malini Iyengar; Mary Ann Lukas; Paul Ordronneau; Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-07-08       Impact factor: 3.738

2.  The bioequivalence of fixed-dose combination tablets of bisoprolol and ramipril and its drug-drug interaction potential.

Authors:  Jan Sus; Jade Huguet; Jan Bosak; Beatrice Setnik; Tomas Hauser; Eric Sicard
Journal:  Clin Transl Sci       Date:  2021-09-08       Impact factor: 4.689

3.  Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril.

Authors:  Michael A Weber; Jan Basile; Manfred Stapff; Barbara Khan; Dongli Zhou
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-06-04       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.